Tamara Turoff Keough Joins UsA2 as Chief Development Officer

Brings 25 Years of Fundraising Experience and a Personal Commitment to Stopping Alzheimer’s 

Washington, D.C. (May 6, 2020) – UsAgainstAlzheimer’s today announced Tamara Turoff Keough, a fundraising leader with 25 years of experience at public policy and other non-profit organizations, as its new Chief Development Officer.

Keough has worked the past six years at the RAND Corporation, where she is currently the senior director of regional giving. She has led a range of individual and institutional giving programs at RAND, and manages major gift officers across the country,

“Tamara’s extensive experience in fundraising and in leading teams will be vital in enabling UsAgainstAlzheimer’s to continue its mission to end Alzheimer’s,” said Russ Paulsen, Chief Operating Officer of UsAgainstAlzheimer’s.

Prior to her work with RAND, Keough was director of development for the Center for the Art of Performance at UCLA (CAP UCLA) for two years and senior director of development at the UCLA School of Theater, Film and Television for three years. She previously worked for nearly three years as development director for RAND’s Policy Circle. Earlier in her career, she worked seven years for the Geffen Playhouse in Los Angeles, rising from a development associate to annual fund manager to the development director.

“I’m excited about the chance to roll up my sleeves and work side-by-side with donors and staff who are motivated to help UsA2 reach its ambitious goal of stopping Alzheimer’s,” Keough said. “For me, it’s also deeply personal. My family has a history of dementia, and I’ve witnessed the struggles first-hand. Having the chance to bring my experience to this field is an inspiration that I’d not felt possible before.”

Keough is a graduate of the Ohio State University.


About UsAgainstAlzheimer’s

UsAgainstAlzheimer’s (UsA2) is a disruptive advocacy and research-focused organization that is pushing for expanding treatments and accelerating towards a cure for Alzheimer’s disease. UsA2’s transformative programming is laser-focused on proactive brain health across the lifespan and understanding what matters most across the lived experiences of those affected by Alzheimer’s in the service of preventing, treating and curing this disease.  We are working to ensure that all communities have their voices heard and get a chance to be brain healthy from the earliest years while building resistance against possible cognitive decline.